Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension

NCT03592667 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Dapagliflozin
DRUG: Placebo - Cap

Sponsor

University of Guadalajara